PHPSX (ProFunds:Pharmaceut;Svc)
Net Asset Value: 14.60 1-Day Return: 0.06 (0.41%) YTD Return as of 4/4/13:Up 24.89%

Classification: Diversified Lvg Funds   Objective: Equity Leverage   Open to New Investors: Yes

Lipper Rating

Total Return Consistent Return Preservation Tax Efficiency Expense

The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.

NAV Chart | Growth of $10,000
Fund Chart

Total Returns (As of 4/04/2013)

More
 YTD1Yr3Yr5Yr10Yr
Fund 24.89 38.97 20.86 12.32 3.17
Classification 12.48 15.78 11.41 -1.86 6.81
Index (S&P 500)NANANANANA
% Rank in Class (1-best,100=worst)2015241076

Fund Stats

More
Investment Objective:Equity Leverage
Net Assets ($Mil)8.60
Inception Date:6/28/00
Manager Name, TenureHratch Najarian, 2011
Expense Ratio: 2.73%
Sales Charge:
Load Type:
 
Level Load
0.00%
0.00%

Top 10 Holdings (As of 7/31/12)

More
Company NameSymbol% Net Assets
Johnson & Johnson Ord JNJ 12.42
Pfizer Inc Ord PFE 11.81
Merck & Co Inc Ord MRK 8.80
Abbott Laboratories Ord ABT 6.84
Bristol-myers Squibb Co Ord BMY 3.95
Eli Lilly And Co Ord LLY 2.85
Allergan Inc Ord AGN 1.64
Watson Pharmaceuticals Inc Ord NA 0.66
Perrigo Co Ord PRGO 0.65
Mylan Inc Ord MYL 0.64
% of Total Holdings 50.26

View Overview for: